FRANKIE DAVIS: Open Payments
NPI 1073679668 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,928 in 183 payments from 24 companies in 2025. Trend: 2023 $4,591 · 2024 $5,694 · 2025 $3,928
Food & beverage: $3,928
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $720 |
| UCB, Inc. | 23 | $605 |
| Amgen Inc. | 21 | $422 |
| Novartis Pharmaceuticals Corporation | 22 | $336 |
| Mallinckrodt Hospital Products Inc. | 10 | $318 |
| Janssen Biotech, Inc. | 11 | $216 |
| ANI Pharmaceuticals, Inc. | 12 | $210 |
| GlaxoSmithKline, LLC. | 9 | $205 |
| AstraZeneca Pharmaceuticals LP | 9 | $201 |
| PFIZER INC. | 10 | $191 |
Products named: Bimzelx, RINVOQ, COSENTYX, ACTHAR, KRYSTEXXA, TREMFYA, SKYRIZI, SOVUNA.
Industry payments across GA — which companies pay providers there.
